These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37834237)

  • 1. An Intrabody against B-Cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex.
    Wang T; Wang C; Wang J; Wang B
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule.
    Kim WT; Seo Choi H; Min Lee H; Jang YJ; Ryu CJ
    Stem Cells; 2014 Oct; 32(10):2626-41. PubMed ID: 24898727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
    Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
    J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BAP31 intrabody induces gastric cancer cell death by inhibiting p27
    Chen J; Guo H; Jiang H; Namusamba M; Wang C; Lan T; Wang T; Wang B
    Int J Cancer; 2019 Apr; 144(8):2051-2062. PubMed ID: 30338855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of N-linked glycosylation in EpCAM affected cell adhesion in breast cancer cells.
    Liu X; Gao J; Sun Y; Zhang D; Liu T; Yan Q; Yang X
    Biol Chem; 2017 Sep; 398(10):1119-1126. PubMed ID: 28315854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deglycosylated EpCAM regulates proliferation by enhancing autophagy of breast cancer cells via PI3K/Akt/mTOR pathway.
    Yang L; Wang Q; Zhao Q; Yang F; Liu T; Huang X; Yan Q; Yang X
    Aging (Albany NY); 2022 Jan; 14(1):316-329. PubMed ID: 34983878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
    Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
    Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
    Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
    Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Regulatory Mechanism of EpCAM N-Glycosylation-Mediated MAPK and PI3K/Akt Pathways on Epithelial-Mesenchymal Transition in Breast Cancer Cells.
    Wen R; Lin H; Li X; Lai X; Yang F
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(5):192-201. PubMed ID: 36029498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM.
    Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O
    Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas.
    Pauli C; Münz M; Kieu C; Mack B; Breinl P; Wollenberg B; Lang S; Zeidler R; Gires O
    Cancer Lett; 2003 Apr; 193(1):25-32. PubMed ID: 12691820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.
    Panda SS; Lee CC; Geevimaan K; Chen KC; Yang SH; Shen CN; HuangFu WC; Wu HC
    J Biomed Sci; 2024 Jul; 31(1):72. PubMed ID: 39010070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells.
    Zhang D; Yang L; Liu X; Gao J; Liu T; Yan Q; Yang X
    J Cell Physiol; 2020 Apr; 235(4):3626-3633. PubMed ID: 31584203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
    English DP; Bellone S; Schwab CL; Roque DM; Lopez S; Bortolomai I; Cocco E; Bonazzoli E; Chatterjee S; Ratner E; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Santin AD
    Cancer; 2015 Feb; 121(3):403-12. PubMed ID: 25251053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ganglioside expression and anti-cancer effects of the monoclonal antibody against epithelial cell adhesion molecule in colon cancer.
    Kwak DH; Ryu JS; Kim CH; Ko K; Ma JY; Hwang KA; Choo YK
    Exp Mol Med; 2011 Dec; 43(12):693-701. PubMed ID: 22033101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell adhesion molecule fragments and signaling in primary human liver cells.
    Gerlach JC; Foka HG; Thompson RL; Gridelli B; Schmelzer E
    J Cell Physiol; 2018 Jun; 233(6):4841-4851. PubMed ID: 29150960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.
    Ruf P; Gires O; Jäger M; Fellinger K; Atz J; Lindhofer H
    Br J Cancer; 2007 Aug; 97(3):315-21. PubMed ID: 17622246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S; Black J; English DP; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Ferrari F; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Am J Obstet Gynecol; 2016 Jan; 214(1):99.e1-8. PubMed ID: 26272866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.